Skint-If the patent is solid for any use or purpose, with particular reference to "also covers pharmaceutical compositions containing PBT2" the rush of interest from outside would have overwhelmed them.
Not making excuses but they would not be prepared or be staffed to cope.
I hope they have obtained the appropriate external help--if they are negotiating!
PBT2 from the Doherty Institute news site., page-15
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
